After grabbing 0.54 million shares, the institutional investor is now in possession of 0.54 million shares of the Basic Materials Company. The new investment brought the stake of investor firm to 0.36% having worth around $0.12 million. Moreover, Renaissance Technologies LLC increased its share by 0.27 million to have a control over 0.31 million shares. And Virtu Financial BD LLC raised its holdings to 27161.0 shares by acquiring 0.11 million shares or 0.07% of the stake.
General Moly Inc. (GMO) concluded trading on 08/26/20 at a closing price of $0.16, with 10.64 million shares of worth about $1.7 million changed hands on the day. Weekly performance of the stock remained positive as price took a surge of 10.22% during that period and on Wednesday the price saw a gain of about 51.85%. Currently the company’s common shares owned by public are about 152.32M shares, out of which, 82.50M shares are available for trading.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 14 times over the past 12 months. They bought 13,001,111 shares in 9 of the transactions. In 5 selling transactions, insiders dumped 473,592 shares.
Vanguard Total Stock Market Index, Vanguard Extended Market Index Fu, and Bridgeway Ultra Small Company Mar are the top 3 mutual funds which are holding stakes in General Moly Inc. Vanguard Total Stock Market Index is currently holding 1.63 million shares of worth totaling $0.36 million. The company recently came buying 0.0 shares which brought its stake up to 1.07% of the company’s outstanding shares. Bridgeway Ultra Small Company Mar, after buying 0.42 million shares, have now control over 0.27% of the stake in the company. It holds 0.42 million shares of worth $91740.0.
General Moly Inc. (AMEX: GMO) started trading at $0.11, below $0.0 from concluding price of the previous day. However, the stock finished the trading on the day at a closing price of $0.16, or with a gain of 51.85%. Stock saw a price change of 10.22% in past 5 days and over the past one month there was a price change of -39.57%. Year-to-date (YTD), GMO shares are showing a performance of -27.85% which decreased to -4.26% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.10 but also hit the highest price of $0.37 during that period. While comparing its average daily trading volume of 1.13 million shares, we see that about 10.64 million changed hands on the day. The stock is currently trading -22.94% below its 20-day simple moving average (SMA20), while that difference is down -27.46% for SMA50 and it goes to -23.73% lower than SMA200.
Bridgeway Capital Management, Inc.. acquired 0.54 million shares of General Moly Inc. having value of about $0.12 million. General Moly Inc. (AMEX: GMO) currently have 152.32M outstanding shares and institutions hold larger chunk of about 4.90% of that. Holding of mutual funds in the company is about 2.52% while other institutional holders and individual stake holders have control over 62.00% and 2.10% of the stake respectively.
The stock has a current market capitalization of $29.91M and its 3Y-monthly beta is at 0.60. It has posted earnings per share of -$1.42 in the same period. It has Quick Ratio of 0.10. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for GMO, volatility over the week remained 25.50% while standing at 12.74% over the month.
Analysts are in expectations that General Moly Inc. (GMO) stock would likely to be making an EPS of $0 in the current quarter, while forecast for next quarter ESPS is $0 and it is $0 for next year. For the current quarter EPS, analysts have given the company a lowest target $0 which is $0 at the higher side of the target for the same. Stock’s fiscal year EPS is expected to rise by 31.60%. EPS is likely to shrink at an annualized rate of 0.00% for next 5-years, compared to annual growth of 13.80% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by H.C. Wainwright on May 19, 2014 offering a Buy rating for the stock and assigned a target price of $1.70 to it. Coverage by RBC Capital Mkts stated General Moly Inc. (GMO) stock as an Underperform in their note to investors on March 27, 2009, suggesting a price target of $1.30 for the stock. On November 10, 2008, RBC Capital Mkts Downgrade their recommendations, while on November 05, 2008, Dahlman Rose Initiated their ratings for the stock with a price target of. Stock get a Mkt perform rating from Friedman Billings on August 13, 2008.